GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 94, No. 4 ( 2004-03-05), p. 462-470
    Abstract: We examined the function of α 4 β 1 integrin in angiogenesis and in mediating endothelial cell responses to the angiogenesis modulators, thrombospondin-1 and thrombospondin-2. α 4 β 1 supports adhesion of venous endothelial cells but not of microvascular endothelial cells on immobilized thrombospondin-1, vascular cell adhesion molecule-1, or recombinant N-terminal regions of thrombospondin-1 and thrombospondin-2. Chemotactic activities of this region of thrombospondin-1 and thrombospondin-2 are also mediated by α 4 β 1 , whereas antagonism of fibroblast growth factor-2–stimulated chemotaxis is not mediated by this region. Immobilized N-terminal regions of thrombospondin-1 and thrombospondin-2 promote endothelial cell survival and proliferation in an α 4 β 1 -dependent manner. Soluble α 4 β 1 antagonists inhibit angiogenesis in the chick chorioallantoic membrane and neovascularization of mouse muscle explants. The latter inhibition is thrombospondin-1–dependent and not observed in explants from thrombospondin-1 −/− mice. Antagonizing α 4 β 1 may in part block proangiogenic activities of thrombospondin-1 and thrombospondin-2, because N-terminal regions of thrombospondin-1 and thrombospondin-2 containing the α 4 β 1 binding sequence stimulate angiogenesis in vivo. Therefore, α 4 β 1 is an important endothelial cell receptor for mediating motility and proliferative responses to thrombospondins and for modulation of angiogenesis.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2004
    detail.hit.zdb_id: 1467838-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 76, No. 14_Supplement ( 2016-07-15), p. 1352-1352
    Abstract: CD47 is a widely expressed cell surface receptor that serves as a counter-receptor for SIRPα in recognition of self by the innate immune system. On the other hand CD47 also serves as a signaling receptor for the matricellular protein thrombospondin-1 (TSP-1), regulating cell growth and survival. Clinical studies consistently show that increased expression of CD47 is an independent poor prognosis factor in several types of cancer, including breast cancer. Moreover elevated expression of CD47 is associated with development of resistance to chemotherapy by inhibiting cell death pathways. Therefore, agents targeting CD47 are attractive to overcome therapeutic resistance in breast cancer. Using a high-throughput assay in a 1536-well microplate format we screened a comprehensive set of approved and late stage development oncology drugs in combination with an anti-CD47 morpholino to find combinatorial strategies that are more cytotoxic against breast cancer cells. Potency and efficacy measurements during the primary screen identified compounds that synergized with anti-CD47 to augment their cytotoxicity effect. One of the compound groups that demonstrated increased synergism with CD47 were the anthracycline family of drugs. We further validated these results in a syngeneic model of breast cancer and demonstrated that blockade of CD47 in combination with doxorubicin improves chemotherapeutic response when compared to mice administered doxorubicin alone. Furthermore the anti-tumor response with anti-CD47 combination is associated with a reduction in glycolytic flux and a selective up regulation of mitophagy. Overall this indicates that blockade of CD47 in the clinic may synergize with chemotherapeutic strategies to improve patient curative responses. Citation Format: David D. Roberts, Ashley Smith, John M. Sipes, Adam Wilson, Lesley Mathews-Griner, Rajarshi Guha, Craig J. Thomas, Marc Ferrer, David R. Soto-Pantoja. High-throughput matrix screening reveals synergistic chemotherapeutic combinations with blockade of CD47 to enhance cytotoxicity in breast cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1352.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2016
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2017
    In:  Cancer Research Vol. 77, No. 13_Supplement ( 2017-07-01), p. LB-213-LB-213
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 13_Supplement ( 2017-07-01), p. LB-213-LB-213
    Abstract: Colon cancer is major public health concern with over 50,000 deaths annually in the US. Environmental and genetic factors influence colon cancer progression, and expression of thrombospondin-1 (TSP1) inversely correlates with colon cancer aggressiveness. TSP1 is a matricellular protein that regulates vascular physiology and tissue responses to stress. We previously demonstrated that deleting the TSP1 (Thbs1) gene in ApcMin/+ mice results in systemic metabolic changes as assessed in liver tissue, increased tumorigenesis, and lower survival of mice fed a low fat diet. We now show that TSP1 induces changes in intestinal microbiota that may cause shifts in secondary bile acid metabolism that influence colon carcinogenesis. Mice were maintained and bred at least two generations on a low fat western diet to equalize dietary effects on their epigenetic context and microbiomes. Mice were pair-fed a low fat or a 21% high-fat western diet beginning at weaning. Mouse fecal matter was collected 8 weeks after dietary exposures and subjected to 16S sequencing for bacterial population identification. Lactobacillaceae, Lachnopiraceae, Ruminococcacea, Verrucomicrobiaceae families were present in all groups. The family Verrucomicrobiaceae and its genus Akkemensi represented a high proportion of the bacterial population. The relative levels of Akkemensia were elevated in low fat fed mice in mice ApcMin/+ and Thbs1−/−:ApcMin/+ when compared to WT counterparts. Interestingly Akkenmensia abundance was reduced in ApcMin/+ mice fed a high-fat diet when compared to other groups. The relative population of the genus Ruminococcus was reduced in Thbs1−/− mice as well as in Thbs1−/−:ApcMin/+ mice fed low and high fat diets, suggesting that these population shifts are driven by genotype. Because intestinal bacteria can alter metabolism, particularly of bile acids, we collected large intestine tissue from mice and subjected it to metabolomics analysis. Our data showed primary and secondary bile metabolism were regulated by the absence of TSP1 in mice fed a high fat diet when compared to WT. High 6-beta-hydroxylithocholate levels were associated with onset of carcinogenesis since it was elevated in ApcMin/+ and Thbs1−/−:ApcMin/+ mice but not in WT or Thbs1−/−. 6-oxolithocholate, hyocholate and hyodeoxycholate were elevated only in ApcMin/+ mice fed a high fat diet but not in Thbs1−/−:ApcMin/+, suggesting that these metabolites contribute to the shift in survival and carcinogenesis observed between low and high fat diets. On the other hand levels of taurohyodeoxycholic acid, 3-dehydrocholate, 7-ketodeoxycholate were elevated in Thbs1−/−:ApcMin/+ and Thbs1−/− mice but not in ApcMin/+, indicating that changes in these metabolites are driven by the loss of Thbs1 and may pre-dispose mice to increased carcinogenesis when fed a high fat diet. Taken together our data shows an unexpected role of TSP1 in regulation of microbiota and bile acid metabolism and reveals potential targets for prevention and treatment of colorectal cancer. Citation Format: David R. Soto-Pantoja, John M. Sipes, Brian Westwood, Nicole Morris, Nancy J. Emenaker, David D. Roberts. Thrombospondin-1 regulates intestinal microbiota and bile acid metabolism in a murine model of colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-213. doi:10.1158/1538-7445.AM2017-LB-213
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 74, No. 19_Supplement ( 2014-10-01), p. 2434-2434
    Abstract: Even though, molecular profiling of breast cancer has allowed for the development of new therapeutic drugs, cytotoxic chemotherapy remains a primary mode of therapy for many breast cancer patients including those diagnosed with triple negative breast cancer. Pre-clinical and clinical studies demonstrate that increased expression of CD47 is associated with poor prognosis in several types of cancer, including breast tumors. Our published evidence shows that blockade of CD47 enhances radiation-induced growth delay of tumors while remarkably protecting soft tissues from death associated to ionizing radiation. We now show that CD47 blockade significantly sensitizes breast tumors to anthracycline chemotherapy while protecting cardiac tissue from the off target effects of this drug. 4T1B breast cancer cells were implanted in the mammary fat-pad of Balb/C mice and treated with saline, doxorubicin, CD47 morpholino (CD47M), or CD47M with doxorubicin. Tumors of mice treated with saline tripled in size. Doxorubicin treatment caused a reduction in tumor volume and weight, but combining CD47 blockade and doxorubicin further reduced tumor volume by over 60%. The reduction of tumor growth was associated with an increased in PINK1 and Parkin gene expression, indicating activation of mitochondrial turnover by mitophagy. Further studies using the Seahorse XF-24 analyzer indicated that blockade of CD47 reduced glycolytic and mitochondrial metabolism measured as the extracellular acidification rate and oxygen consumption rate in 4T1B cells and human MDA-MB-231 cells. The regulation of glycolytic mechanism is associated with a reduction in glucose uptake and reduction in Glut-1 expression in breast tumors. Metastatic spread of tumors to lungs was observed in saline treated animals. Immunohistological analysis indicated that these lesions express CD47. Moreover, we observed positive immunoreactivity to CD47 in clinical samples of metastatic breast carcinoma indicating that CD47 signaling may play an important role in tumor spread and its targeting could lead to reduction of metastatic burden. One of the most common side effects of doxorubicin chemotherapy is cardiac toxicity. Blockade of CD47 in tumor bearing mice protected cardiac tissue indicated by reduction in fibrosis and cell death. This was associated by an increase in autophagy gene expression as demonstrated by the observed increase in ATG5 and ATG7. Therefore blockade CD47 enhances doxorubicin reduction of breast tumor growth in a syngeneic tumor model indicating that CD47 potentiates anthracycline-mediated breast tumor therapy while protecting normal tissue from death associated with cytotoxic therapy. Citation Format: David R. Soto-Pantoja, John M. Sipes, Arunima Ghosh, Maria J. Merino, David D. Roberts. Therapeutic targeting of CD47 regulates cell bioenergetics and autophagy to reduce breast tumor growth and protect against anthracycline-mediated cardiac toxicity. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2434. doi:10.1158/1538-7445.AM2014-2434
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2014
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2015
    In:  Cancer Research Vol. 75, No. 15_Supplement ( 2015-08-01), p. 1202-1202
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 1202-1202
    Abstract: Over 140,000 people will be diagnosed with colorectal cancer in the United States this year, indicating an urgent need to develop therapeutic and dietary strategies to prevent and improve outcomes of this disease. The goal of this study was to determine the biochemical profiles of large intestine originating from wild type, thrombospondin-1 (thbs1) null, ApcMin/+ and ApcMin/+thbs1-/-mice, with the aim of identifying metabolic changes associated with variation in dietary lipids in the presence/absence of thrombospondin-1 (TSP1) as impacting tumorigenesis and tumor burden in ApcMin/+ animals. Our data indicates that expression of TSP1 in the APC-min mouse prevents the development of adenomas in the large intestine in mice fed low fat or high fat diets. On the other hand, lack of TSP1 increases tumor multiplicity in these mice, and up-regulates Ki67 in intestinal tissue. In the current study, general indications of greater uptake and utilization of glucose through glycolysis, as suggested by accumulation of glucose and lactate, in large intestine tissue were noted in the thbs1 null, ApcMin/+, and Apcmin/+thbs1-/- groups upon feeding of a high-fat diet. However, in high fat diet-fed Apcmin/+thbs1-/- mice, reductions in the pentose phosphate pathway (PPP) intermediates 6-phosphogluconate and the isobaric compounds ribulose/xylulose 5-phosphate, along with elevations in ribulose and ribose were also observed. These findings may be indicative of increased glucose utilization through the PPP in Apcmin/+thbs1-/- mice fed a high-fat diet, presumably to support nucleotide synthesis and anabolic processes related to tumor growth and proliferation in the large intestine. Moreover, while elevations in several amino sugars (UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, and UDP-N-acetylgalactosamine) were noted in WT mice fed a high-fat diet, a marked reduction in these metabolites was observed in Apcmin/+thbs1-/- mice fed a high-fat diet. As amino sugars are synthesized from glucose and play an important role in extracellular matrix structure and cellular communication, changes in these metabolites may be related to alterations in rates of synthesis and/or tumor growth and proliferation. While increased glucose utilization through glycolysis was apparent in large intestine tissue from all of the groups genetically predisposed to development of cancerous lesions and fed a high-fat diet, changes in PPP activity and amino sugars were limited to the Apcmin/+thbs1-/- group. Therefore, these findings may be indicative of metabolic changes that are unique to Apcmin/+thbs1-/- mice, which are particularly susceptible to tumor formation. Therefore these data suggest that TSP1 regulates progression of colon carcinogenesis and define metabolic targets of TSP1 that may contribute to prevention of colorectal cancer. Citation Format: David R. Soto-Pantoja, John M. Sipes, Nicole Morris, Nancy J. Emmenaker, David D. Roberts. Thrombospondin-1 regulates energy metabolism to increase carcinogenesis in an in vivo model of colorectal cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1202. doi:10.1158/1538-7445.AM2015-1202
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...